Spots Global Cancer Trial Database for gemcitabine and cisplatin
Every month we try and update this database with for gemcitabine and cisplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy | NCT02452970 | Cholangiocarcin... | RRx-001 Gemcitabine and... | 18 Years - | EpicentRx, Inc. | |
| Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | NCT00601159 | Metastatic Brea... | gemcitabine and... | 18 Years - 75 Years | Fudan University | |
| Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer | NCT00696007 | Transitional Ce... | Gemcitabine and... Retrospective c... | 18 Years - | Lahey Clinic | |
| Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma | NCT01261728 | Urothelial Carc... | Gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation | NCT03684811 | Cohort 1a and 1... Cohort 2a and 2... Cohort 3a and 3... Cohort 4a and 4... Cohort 5a: Othe... | FT-2102 Azacitidine Nivolumab Gemcitabine and... | 18 Years - | Novo Nordisk A/S | |
| Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma | NCT05823311 | Advanced Cholan... | Lenvatinib, tis... Gemcitabine and... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer | NCT05531123 | Bladder Cancer | Tislelizumab gemcitabine and... Modified hypofr... | 18 Years - 85 Years | Fudan University | |
| Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer | NCT05189028 | Cervical Cancer Neoadjuvant Che... | gemcitabine and... | 18 Years - 70 Years | Shantou University Medical College | |
| 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma | NCT02512692 | Intrahepatic Ch... | SIR-Spheres mic... Gemcitabine Cisplatin | 18 Years - | Medical University of South Carolina | |
| HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors | NCT05173142 | Solid Tumor | HMPL-453 gemcitabine and... toripalimab Docetaxel | 18 Years - 75 Years | Hutchmed | |
| Lenvatinib, Tislelizumab Combined With Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma | NCT05823311 | Advanced Cholan... | Lenvatinib, tis... Gemcitabine and... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer With Homologous Recombination Deficiency That Has Spread to the Liver | NCT05182112 | Pancreatic Canc... | Whole liver irr... Gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer | NCT01734798 | Locally Advance... | Radiation gemcitabine and... Radiotherapy an... | 18 Years - 70 Years | Cairo University | |
| Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer | NCT05189028 | Cervical Cancer Neoadjuvant Che... | gemcitabine and... | 18 Years - 70 Years | Shantou University Medical College | |
| HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | NCT04961970 | Intrahepatic Ch... | oxaliplatin , f... gemcitabine and... | 18 Years - 75 Years | Sun Yat-sen University | |
| Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV | NCT01003964 | Non Small Cell ... | IP GP | 18 Years - | National Cancer Center, Korea | |
| Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | NCT01528618 | Nasopharyngeal ... | gemcitabine and... 5-Fluorouracil ... | 18 Years - | Sun Yat-sen University | |
| Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | NCT00601159 | Metastatic Brea... | gemcitabine and... | 18 Years - 75 Years | Fudan University | |
| A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation | NCT03684811 | Cohort 1a and 1... Cohort 2a and 2... Cohort 3a and 3... Cohort 4a and 4... Cohort 5a: Othe... | FT-2102 Azacitidine Nivolumab Gemcitabine and... | 18 Years - | Novo Nordisk A/S | |
| GP vs PF as Induction Chemotherapy Combined With CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT03840421 | Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Head and Neck N... | gemcitabine and... cisplatin and f... IMRT cisplatin | 18 Years - 65 Years | Sun Yat-sen University | |
| A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies | NCT06181032 | Biliary Tract M... | Adebrelimab Apatinib Gemcitabine Cisplatin | 18 Years - 75 Years | First Affiliated Hospital of Fujian Medical University | |
| Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients With Advanced Cholangiocarcinoma | NCT05532059 | Advanced Cholan... | Lenvatinib, tis... gemcitabine and... | 18 Years - 85 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
